athenahealth, Inc. (NASDAQ:ATHN) SVP Jonathan D. Porter sold 422 shares of the company’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $154.00, for a total value of $64,988.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Jonathan D. Porter also recently made the following trade(s):

  • On Monday, July 17th, Jonathan D. Porter sold 300 shares of athenahealth stock. The shares were sold at an average price of $143.13, for a total transaction of $42,939.00.
  • On Thursday, June 15th, Jonathan D. Porter sold 300 shares of athenahealth stock. The shares were sold at an average price of $142.27, for a total transaction of $42,681.00.
  • On Monday, May 15th, Jonathan D. Porter sold 300 shares of athenahealth stock. The shares were sold at an average price of $109.48, for a total transaction of $32,844.00.

Shares of athenahealth, Inc. (ATHN) traded up 8.44% on Friday, hitting $155.93. 2,286,356 shares of the company’s stock were exchanged. The company’s 50-day moving average price is $141.51 and its 200 day moving average price is $122.62. athenahealth, Inc. has a 12-month low of $90.11 and a 12-month high of $158.66. The stock has a market cap of $6.21 billion, a price-to-earnings ratio of 306.95 and a beta of 1.79.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.12. The business had revenue of $301.10 million for the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a net margin of 1.84% and a return on equity of 5.93%. The business’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.34 earnings per share. On average, equities analysts predict that athenahealth, Inc. will post $1.86 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/07/21/insider-selling-athenahealth-inc-athn-svp-sells-422-shares-of-stock.html.

A number of brokerages have recently weighed in on ATHN. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $142.00 price objective on shares of athenahealth in a report on Wednesday, April 19th. UBS AG set a $123.00 price objective on shares of athenahealth and gave the company a “buy” rating in a report on Monday, May 1st. Piper Jaffray Companies reissued a “buy” rating and set a $152.00 price objective on shares of athenahealth in a report on Friday, July 14th. William Blair reissued a “market perform” rating on shares of athenahealth in a report on Friday. Finally, Barclays PLC set a $88.00 price objective on shares of athenahealth and gave the company an “underweight” rating in a report on Monday, May 1st. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and twelve have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $143.33.

Several hedge funds have recently modified their holdings of the stock. FNY Partners Fund LP increased its stake in shares of athenahealth by 1,900.0% in the first quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock valued at $112,000 after buying an additional 950 shares during the last quarter. Russell Investments Group Ltd. purchased a new stake in shares of athenahealth during the fourth quarter valued at $118,000. Teza Capital Management LLC purchased a new stake in shares of athenahealth during the first quarter valued at $220,000. Comerica Bank purchased a new stake in shares of athenahealth during the fourth quarter valued at $299,000. Finally, Arxis Securities LLC purchased a new stake in shares of athenahealth during the first quarter valued at $304,000.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.